Most bladder cancers occur in people older than 55 years, with 73 being the average age of diagnosis. During the past 20 years, the incidence of bladder cancer (BC) has declined, but men continue to be 3 to 4 times more likely to develop bladder cancer than women. Incidence of BC is diagnosed more often in White people than in Black people or Hispanic Americans.
The goal of this course is to provide nurses and physicians with an overview of bladder cancer, including risk factors, signs and symptoms, diagnostic tests, staging, and treatment.
Most bladder cancers occur in people older than 55 years, with 73 being the average age of diagnosis. During the past 20 years, the incidence of bladder cancer (BC) has declined, but men continue to be 3 to 4 times more likely to develop bladder cancer than women. Incidence of BC is diagnosed more often in White people than in Black people or Hispanic Americans. The goal of this course is to provide nurses and physicians with an overview of bladder cancer, including risk factors, signs and symptoms, diagnostic tests, staging, and treatment.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Georgia Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 1.00 AMA PRA category 1 Credits™
Outline:
Anatomy of the Urinary Bladder
Section 3: Bladder Cancer Treatment
Systemic Therapies for Metastatic Bladder Cancer
Section 4: Considerations for the Interprofessional Team
The Role of the Healthcare Professional
Monica Caicedo Orellana, MS, RN, OCN, is an SME writer for Relias with over 16 years of acute care experience in nursing. She is licensed as a professional registered nurse in the State of New York. She obtained her OCN certification in 2008. She has served in several leadership roles in the acute care setting, within the Medical Surgical Division, mentoring nurses in renal and oncology specialties, and the role of nurse educator. She has been involved in various institutional committees and quality improvement projects. Monica earned a master’s degree in nursing education from New York University Rory Meyers College of Nursing.
Disclosure: Monica Caicedo Orellana, MS, RN, OCN, CNE has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.